Cord blood stem cells - The basic science

Frontiers of Cord Blood Science

Volumn , Issue , 2009, Pages 19-25

  Hollands, Peter ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77149123670     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84800-167-1_2     Document Type: Chapter

References (36)

1. Gluckman E, Broxmeyer HA, Auerbach A.D., et al Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989; 321:1174-1178.
2. Laughlin MJ, Eapen M, Rubinstein P., et al Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukaemia. N Engl J Med. 2004; 351: 2265-2275.
3. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, et al Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 2006; 37:439-449.
4. Brunstein CG, & Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med. 2006; 57:403-417.
5. Kurtzberg J, Drapkin-Lyerly A, & Sugarman, J. Untying the Gordian knot: policies, practices and ethical issues related to banking of umbilical cord blood. J Clin Invest. 2005; 115: 2592-2597.
6. Rocha V, Labopin M, Sanz G., et al; Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukaemia. N Engl J Med. 2004; 351:2276-2285.
7. Hamza NS, Lisgaris M, Yadavalli G.K., et al Infectious complications after unrelated HLAmismatched hematopoietic stem cell transplantation. Blood. 1999; 94:333-339.
8. Mommaas B, Steghuis-Kamp J, van Halteren AG, et al Cord blood comprises antigenexperienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood. 2005; 105:1823-1827.
9. Roy V, & Verfaillie CM. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp Hematol. 27; 1999:302-312.
10. Peled A, Kollet O, Ponomaryov T., et al The chemokine SDF-1 activates the integrins LFA-1, VLA-4 and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood. 2000; 95:3289-3296.
11. Zheng Y, Watanabe N, Nagamura-Inoue T, et al Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Exp Hematol. 2003; 31:1237-1246.
12. Hiruma K, Nakamura H, Henkart P., et al Clonal deletion of postthymic T cell: vetocells kill precursor cytotoxic T lumphocytes. J Exp Med. 1992; 175:863-870.
13. Bender J, Unverzagt K, Walker D., et al Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopathol. 1994; 70:10-18.
14. Gomi S, Hasegawa S, Dan K., et al A comparative analysis of the transplant potential of umbilical cord blood versus mobilized peripheral blood stem cells. Nippon Ika Daigaku Zasshi. 1997; 64:307-313.
15. Theunissen K, & Verfaillie C. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp Hematol. 2005; 33:165-172.
16. Ng YY, van Kessel B, Lokhorst HM, et al Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity. J Leukoc Biol. 2004; 75:314-323.
17. Rubinstein P, Carrier C, Scaradavou A., et al Outcomes among 562 recipients of placentalblood transplants from unrelated donors. N Engl J Med. 1998; 339:1565-1577.
18. Wagner JE, Barker JN, DeFor T.E., et al Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLS disparity on treatment-related mortality and survival. Blood. 2002; 100:1611-1618.
19. Rocha V, Wagner JE, Sobocinski K.A., et al; Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. Graftversus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA identical sibling. N Engl J Med. 2000; 342:1846-1854.
20. Michel G, Rocha V, Chevret S., et al; the Eurocord Group. Unrelated cord blood transplantation for childhood acute myeloid leukaemia: a Eurocord Group analysis. Blood. 2003; 102:4290-4297.
21. Chalmers I, Janossy G, Contreras M., et al Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998; 92:11-18.
22. Kadereit S, Deeds LS, Haynesworth S.E., et al Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer. Stem Cells. 2002; 20:573-582.
23. Kadereit S, Mohammad S, Miller R., et al Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood. 1999; 94:3101-3107.
24. Liu E, Law HK, & Lau YL. Tolerance associated with cord blood transplantation may depend on the state of host dendritic cells. Br J Haematol. 2004; 126:517-526.
25. Brahmi Z, Hommel-Berrey G, Smith F., et al NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients. Hum Immunol. 2005; 62:782-790.
26. Laughlin MJ, Barker J, Bambach B., et al Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med. 2001; 344: 1815-1822.
27. Moore MA, & Hoskins I. Ex vivo expansion of cord blood-derived stem cells and progenitors. Blood Cells. 1994; 20:468-479.
28. Van Zant G., Drubachevsky I, Rummel S., et al Expansion of hematopoietic progenitor cells from umbilical cord blood via continuous perfusion culture. Blood Cells. 1994; 20:482-491.
29. Lewis ID, Almeida-Porada G, Du J., Lemischka IR, Moore KA, Zanjani ED, et al Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood. 2001; 97:3441-3449.
30. Ehring B, Biber K, Upton T.M., et al Expansion of HPCs from cord blood in a novel 3D matrix. Cytotherapy. 2003; 5:490-499.
31. Barker JN, Weisdorf DJ, DeFor T.E., et al Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003; 102:1915-1919.
32. Kogler G, Sensken S, Airey J.A., et al A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004; 200:123-135.
33. Ma N, Stamm C, Kaminski A., Li W, et al Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res. 2005; 66:45-54.
34. Hirata Y, Sata M, Motomura N., et al Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem Biophys Res Commun. 2005; 327:609-614.
35. Ende N, Chen R, & Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun. 2004; 325:665-669.
36. Ende N, Chen R, & Reddi AS. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun. 2004; 321:168-171.